Considering that neferine revealed collateral sensitivity toward drug-resistant cancer cells in a comparable manner to verapamil as demonstrated by the R123 uptake experiment and that neferine interacted in silico with human P-gp strongly, even if R123 was pre-bound, neferine indeed possesses the potential as a promising drug candidate to fight against MDR. Here, PGP is linked to cancer.